2020
DOI: 10.3201/eid2604.190406
|View full text |Cite
|
Sign up to set email alerts
|

Recurrent Herpes Simplex Virus 2 Lymphocytic Meningitis in Patient with IgG Subclass 2 Deficiency

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…23 Whole exome sequencing in patients with recurrent HSV2 meningitis has detected rare genetic variants related to ubiquitin proteasome, autophagy, and cell proliferation pathways, suggesting that affected patients may have an underlying immune defect. 24,25 Varicella Zoster Virus (VZV)…”
Section: Herpes Simplex Virus 2 (Hsv2)mentioning
confidence: 99%
“…23 Whole exome sequencing in patients with recurrent HSV2 meningitis has detected rare genetic variants related to ubiquitin proteasome, autophagy, and cell proliferation pathways, suggesting that affected patients may have an underlying immune defect. 24,25 Varicella Zoster Virus (VZV)…”
Section: Herpes Simplex Virus 2 (Hsv2)mentioning
confidence: 99%
“…HSV2 has also been shown to be a major cause of recurrent lymphocytic meningitis (also referred to as Mollaret meningitis) [ 47 •]. Recent work has identified specific genetic variants associated with altered immune signaling pathways in patients with recurrent HSV2 meningitis, which may explain why these patients are predisposed to recurrent CNS reactivation [ 48 ]. The current treatment recommendation for HSV2 meningitis is IV acyclovir (5–10 mg/kg every 8 hours) until clinical improvement is observed followed by high-dose oral valacyclovir (1 g three times a day) for a total duration of antiviral treatment of 10–14 days [ 49 ].…”
Section: Herpes Simplex Virusmentioning
confidence: 99%